Detalhe da pesquisa
1.
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer.
Genes Dev
; 35(3-4): 218-233, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446568
2.
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
Genes Dev
; 33(11-12): 641-655, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048544
3.
Insights into gemcitabine resistance and the potential for therapeutic monitoring.
Metabolomics
; 14(12): 156, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30830412
4.
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells.
J Proteome Res
; 16(10): 3536-3546, 2017 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28809118
5.
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Proc Natl Acad Sci U S A
; 109(34): 13787-92, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869720
6.
Systems-based approaches to study immunometabolism.
Cell Mol Immunol
; 19(3): 409-420, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121805
7.
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function.
Sci Immunol
; 7(69): eabm0631, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35275752
8.
High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions.
Commun Biol
; 3(1): 271, 2020 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472013
9.
Cysteine depletion induces pancreatic tumor ferroptosis in mice.
Science
; 368(6486): 85-89, 2020 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241947
10.
Metabolic Regulation of Redox Balance in Cancer.
Cancers (Basel)
; 11(7)2019 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31288436
11.
MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
PLoS One
; 12(5): e0176820, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464016
12.
Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
PLoS One
; 12(6): e0179098, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28570622
13.
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Cancer Cell
; 32(1): 71-87.e7, 2017 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28697344
14.
Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3.
Oncotarget
; 6(34): 36019-31, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26440309
15.
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
Cancer Metab
; 2: 18, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25228990
16.
Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma.
PLoS One
; 7(3): e32996, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22412968
17.
Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism.
Cancer Lett
; 323(1): 29-40, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22475682
18.
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Cancer Cell
; 32(3): 392, 2017 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28898700